tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

King International Shareholders Back Capital Mandates but Remove CEO and Independent Director

Story Highlights
  • Shareholders approved financial statements, key director re-elections, auditor, and broad share issue and buyback mandates.
  • The AGM rejected re-election of CEO Yan Ming and independent director Wang Zhenyu, triggering immediate board changes.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
King International Shareholders Back Capital Mandates but Remove CEO and Independent Director

Claim 70% Off TipRanks Premium

Life Healthcare Group ( (HK:0928) ) has provided an update.

At its annual general meeting held on 9 January 2026, King International Investment Limited secured shareholder approval for the adoption of its audited financial statements for the year ended 31 March 2025, the re-election of four executive directors, reappointment of ZHONGHUI ANDA CPA Limited as auditor, and broad mandates to issue up to 20% of its existing share capital and repurchase up to 10%, thereby preserving financial and capital-structure flexibility. However, shareholders voted overwhelmingly against the re-election of executive director and Co-Chairlady and CEO Ms. Yan Ming and independent non-executive director Mr. Wang Zhenyu, leading to their removal from the board with immediate effect and signaling a notable shift in the company’s leadership and governance framework.

More about Life Healthcare Group

King International Investment Limited is a Cayman Islands-incorporated company listed on the Hong Kong Stock Exchange (Stock Code: 928). The announcement relates to its governance and capital management decisions as approved by shareholders at the latest annual general meeting, which shape its board composition and authorities over share issuance and repurchases in the Hong Kong market.

Average Trading Volume: 1,656,702

Technical Sentiment Signal: Buy

Current Market Cap: HK$183.2M

See more insights into 0928 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1